The FDA Just Put Caffeine Labeling on Its 2026 To-Do List. Here's Why That Matters Now.

4 days ago
4 min read

Hands with red nails hold a latte in a white cup, topped with leaf latte art, in a cozy café setting.

For years, caffeine has lived in a strange regulatory blind spot. If a company adds it as a standalone ingredient, it has to show up on the label. If it occurs naturally, like in coffee or chocolate, it doesn't. And in either case, brands have never been required to state exactly how much caffeine is actually in the product. A can of cold brew and a can of an energy drink can sit side by side on a shelf, and only one of them has traditionally had to tell you anything meaningful about its caffeine content at all.

That gap just landed on the FDA's radar in a real way, and it's worth understanding exactly what changed, what didn't, and what it means for your labeling strategy over the next twelve to eighteen months.

What Actually Happened

In late June, the FDA's Human Foods Program quietly added a new item to its 2026 regulatory priority agenda: draft industry guidance on labeling added caffeine content in foods and beverages. The document is titled "Labeling Caffeine Content in Foods and Beverages; Draft Guidance for Industry," and it covers both packaged products and caffeine served at retail or restaurant settings. A representative for the agency told reporters that with the growing consumption of caffeinated beverages and foods, the Human Foods Program intends to highlight industry best practices for labeling added caffeine, connecting packaged foods and beverages with retail and restaurant service.

This is not a final rule. It is not even a proposed rule yet. Guidance documents generally do not carry the force of law, and the FDA has not released draft label language, identified which specific products or categories would be covered, or set any deadline for companies to change labels or menus. For now, no company faces new legal requirements.

But if you have worked in food and beverage regulatory for any length of time, you know how this movie tends to go. Guidance agenda items are the FDA signaling where its attention is heading before the formal process begins. Treating that signal as noise because "nothing is final yet" is exactly how companies end up scrambling eighteen months from now instead of planning calmly today.

Why the Timing Isn't an Accident

This item didn't appear on the agenda in a vacuum. Scrutiny of high caffeine beverages has intensified sharply over the past year, driven largely by growing concern about marketing to teenagers and children. In June 2026, the Texas Attorney General opened an investigation into a major beverage company after a 17 year old consumer of one of its energy drink products died from an enlarged heart allegedly caused by excessive caffeine consumption. That case, and the public attention around it, has put a spotlight on exactly the kind of disclosure gap this guidance is meant to address: products with no obligation to state how much caffeine they actually contain.

Right now, current FDA policy only requires packaged foods and beverages to identify caffeine in the ingredient list when it's added as a standalone ingredient. Naturally occurring caffeine is treated differently, and milligram disclosure has never been mandatory either way. That is precisely the structure this guidance is expected to revisit.

Why This Is Bigger Than Just Caffeine

Caffeine labeling isn't happening in isolation. It is one piece of a broader 2026 push from the Human Foods Program that also touches the criteria for using the word "healthy" on packaging, updated rules around "No Artificial Colors" claims, and transparency requests around ingredient sourcing such as undisclosed rye, barley, and gluten cross-contact in oats. Read together, these items signal an agency leaning harder into ingredient transparency and consumer-facing claims across the board, not just caffeine specifically.

If your brand touches food or beverage in any form, caffeine labeling might be the headline you noticed, but the pattern underneath it is the real story: labeling requirements are trending toward more specificity, not less, and "we've always done it this way" is a shrinking safe harbor across the entire category.

What This Means for Your Label Strategy Today

You don't need to redesign your packaging this quarter. But there is real, low-risk work worth starting now, while there's no deadline pressure and no final language to react to:

Take inventory of every product where caffeine is present, whether added or naturally occurring, and note which ones currently disclose an amount and which don't.
Get ahead of your own documentation. If future guidance eventually asks for specific milligram disclosures, you want formulation records already organized and centralized, not scattered across three departments.
Watch for the actual draft guidance when it publishes. Comment periods are where companies get a real voice in how workable a rule ends up being, and showing up with substantive input matters.
Loop in whoever owns your packaging, marketing, and menu design now, so a future labeling change doesn't become a fire drill that lands on legal's desk with no lead time.
Keep an eye on parallel Human Foods Program priorities, including the "healthy" claim criteria and artificial color labeling, since they may move on overlapping timelines and share review resources.

The Bottom Line

The FDA telegraphed this one clearly, well ahead of any formal rulemaking. Brands that use the runway between now and a published draft guidance will be the ones making calm, deliberate label decisions next year instead of reactive ones under a compressed timeline. The brands that wait for a final rule to force their hand rarely end up in as strong a position, and they rarely get the benefit of shaping the guidance through comment before it's locked in.

If you're trying to figure out where your product portfolio stands against where FDA guidance is heading on caffeine disclosure, that's exactly the kind of conversation worth having before it becomes urgent.